u/marit_mensa

Net peptide content accounts for counterion, water and residual solvent. On some of these compounds the gap between purity and net content is substantial and entirely honest.

Same. Net peptide content is where the difference between the label and the vial actually shows up.

Same method at both labs, or two different gradients?

What wavelength, and what was the gradient?

Can you post the trace with the axes labelled?

Right, and reading the actual supply notice rather than the coverage of it saves a fortnight of speculation.

Agreed — and keeping the letters with dates is what makes any later challenge possible.

I would not read a supply notice as a shortage in your pharmacy tomorrow.

Adding the practical bit — ask what happens at discharge before you start, not after.

the price difference between pharmacies this month is genuinely large

Correction: that is a tailing factor, not a plate count. Different diagnostics for different problems.

Can you post the trace with the axes labelled?

Is that baseline drawn by the software or by hand?

the Irish scheme cap is the single most useful fact in this board

reproducibility beats resolution if you only get one of them

private and NHS pathways are not a ladder, they are separate routes

BMI thresholds vary by ICB and by year

Small fix — that is the Scottish pathway. The post is asking about England and the answer is different.

Cosigning the wavelength point. Half the disagreements in this board are two people looking at different detectors.

Sent the same vial to Medutest and VendorInvestigate. 98.8% against a claimed 98.0%. The difference was the gradient, not the material.

two labs, two gradients, two honest answers

private prescription pricing moves monthly and the pharmacy is most of the spread

Same.

Adding the practical bit — ask what happens at discharge before you start, not after.